Positioning as a Readmission Reduction Tool
'Cost-Saving Structure'

Rising readmissions → Hospital penalties, insurer losses & Medicare cost burden
→ RPM-based reimbursement 'Ecosystem Entry'

8~9M
HF Patients
in the U.S.
1.2M cases
Annual
Hospitalizations

U.S. Market Entry Roadmap

2026 Preparation Phase
Key Goal 1
International Patent Filing
U.S., Japan, China & 4 other countries
Key Goal 2
Apply for U.S. Entry Support Programs
Global Accelerating (GMEP) Support Program
COMPA, CES Innovation Apply Consulting Program
2026 Healthcare Big Data & AI Startup Competition
2027 U.S. Fitness Validation Phase
Key Goal 1
U.S. Voice Data Collection
~100 patients / 90-day F/U
HF Specialty Clinics & RPM-experienced hospitals
Key Goal 2
Product Redesign
Nurse workflow
Stable / Watch / Escalation
Trend visualization
Patient prioritization / Alert filtering
2028 Clinical / Operational / Economic Validation
Key Goal 1
U.S. Expanded Trial (~300–500 patients)
30–90 day readmission reduction
Intervention timing / Nurse workload reduction
Key Goal 2
FDA Pre-submission
HF Worsening Monitoring AI System
Key Goal 3
Economic Model Development
Readmission reduction rate / Monthly cost savings per member
2029~ Commercialization
Key Goal 1
FDA Submission (BDD Track)
Key Goal 2
RPM Operator Partnership
RPM Operator / Virtual care provider
Key Goal 3
EMR Integration
Epic System / Oracle Health
Multimodal